Prostatic Cancer Versus Androgen Deficiency
Not Applicable
Completed
- Conditions
- Cancer of Prostate
- Interventions
- Other: Blood sample
- Registration Number
- NCT02235142
- Lead Sponsor
- Hopital Foch
- Brief Summary
Open study to make a comparison between hypogonadism and euogonadism patients regarding the severity of prostate cancer. The purpose of this study is to determine the importance of the relationship between the hormonal status and the type of the tumor at the time of surgical intervention as well as follow up of the patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 1614
Inclusion Criteria
- Male patients over than 18 years of age, with localized, stage I or II prostate cancer, not receiving local treatment (radiation, phototherapy, thermotherapy,...) or hormonal therapy, showing indication of radical prostatectomy.
Exclusion Criteria
- Absence of radical prostatectomy indication
- Patient received local or hormonal therapy prior to surgery
- Patients already enrolled in other clinical study incompatible with the study
- Patients on a treatment which can affect hormonal level (Prednisone, Ketoconazole, Abiraterone, Finasteride, Dutasteride)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Localised prostat cancer and androgen deficiency Blood sample -
- Primary Outcome Measures
Name Time Method Testosteron Serum level The day prior to surgery Gleason score 5 years
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (8)
CHU Fort de France
🇲🇶Fort-de-France, Martinique
Hôpital Foch
🇫🇷Suresnes, Ile De France, France
Hôpitaux Civils de Colmar
🇫🇷Colmar, France
Clinique Saint Augustin
🇫🇷Bordeaux, France
Hôpital Henri Mondor
🇫🇷Créteil, France
La Pitié-Salpêtrière (AP-HP)
🇫🇷Paris, France
CHU Pointe à Pitre
🇬🇵Pointe-à -Pitre, Guadeloupe
Institut Mutualiste Montsouris
🇫🇷Paris, France